Clinical Research Organization

crobangladesh@gmail.com

 +8801819251514

Facebook-square

Relevant publications

01

Al Mahtab M, Akbar SMF, Aguilar JC, Guillen G, Penton E, Tuero A, Yoshida O, Hiasa Y, Onji M. Treatment of chronic hepatitis B naïve patients with a therapeutic vaccine containing HBs and HBc antigens (a randomized, open and treatment controlled phase III clinical trial). PLoS One. 2018 Aug 22;13 (8): e0201236. doi: 10.1371/journal.pone.0201236. PMID: 30133478; PMCID: PMC6104936.
https://pubmed.ncbi.nlm.nih.gov /30133478/

02

Akbar, S.M.F.; Al Mahtab, M.; Aguilar, J.C.; Yoshida, O.; Penton, E.; Gerardo, G.N.; Hiasa, Y. Sustained Antiviral and Liver Protection by a Nasal Therapeutic Vaccine (NASVAC, Containing Both HBsAg and HBcAg) in Patients with Chronic Hepatitis B:2-Year Follow-Up of Phase III Clinical Trial. Pathogens 2021, 10, 1440. 
https://doi.org/10.3390/pathogens101 11440
https://www.mdpi.com/2076-0817/10/11/1440

03

Akbar, S.M.F.; Al Mahtab, M.; Aguilar, J.C.; Yoshida, O.; Khan, S.; Penton, E.; Gerardo, G.N.; Hiasa, Y. The Safety and Efficacy of a Therapeutic Vaccine for Chronic Hepatitis B: A Follow-Up Study of Phase III Clinical Trial. Vaccines 2022, 10, 45. 
https://doi.org/10.3390/vaccines10010045
https://pubmed.ncbi.nlm.nih.gov /35062707/

04

Al Mahtab M, Akbar SMF, Aguilar JC, Yoshida O, Khan S, Gerardo GN and Hiasa Y (2023) Safety profile, antiviral capacity, and liver protection of a nasal therapeutic vaccine in patients with chronic hepatitis B: Five-year-follow-up outcomes after the end of treatment. Front. Med. 10:1032531. doi: 10.3389/fmed.2023.1032531
https://pubmed.ncbi.nlm.nih.gov /36844221/

05

Mamun Al Mahtab, Sitesh Chandra Bachar, Kakon Nag, Mohammad Mohiuddin, Md. Abdur Rahim, Md. Helal Uddin, Samir Kumar, Md. Maksudur Rahman Khan, Md. Enamul Haq Sarker, Rony Roy, Sourav Chakraborty, Bipul Kumar Biswas, Md. Emrul Hasan Bappi, Ratan Roy, Uttam Barman and Naznin Sultana. Clinical Evaluation of Recombinant Erythropoietin Biosimilar GBPD002 Compared with Eprex® in Adult Human. Archives of Clinical and Biomedical Research 7 (2023):459-474.
www.fortunejournals.com/articles/clinical-evaluation-in-adult-human-revealed-%20the-biosimilarity-of-recombinant-erythropoietin-gbpd002-with-eprexreg.html

06

Nag K, Chandra Baray J, Rahman Khan M, Mahmud A, Islam J, Myti S, Ali R, Haq Sarker E, Kumar S, Hossain Chowdhury M, Roy R, Islam F, Barman U, Khan H, Chakraborty S, Badsha A, Hossain M, Ahammad S, Rahman Chowdhury M, Ghosh P, Islam Shimul R, Ahmmed R, Hussain Bhuiya E, Kumar Biswas B, Mohiuddin M, Sultana N. An mRNA-based vaccine candidate against SARS-CoV-2 elicits stable immuno response with single dose. Vaccine. 2021 Jun 23;39(28):3745-3755. doi: 10.1016/j.vaccine.2021.05.035. Epub 2021 May 18. PMID: 34039497; PMCID: PMC8130517.
https://europepmc.org/article/pmc/pmc8130517